Paediatric HIV/AIDS disclosure: towards a developmental and process-oriented approach

A Lesch1, L Swartz, A Kagee

  • 1Department of Psychology, University of Stellenbosch, Matieland, South Africa. alesch@sun.ac.za

AIDS Care
|June 19, 2007
PubMed

Insights

Disclosing HIV diagnosis to children is crucial as more children with HIV/AIDS live longer. A process-oriented approach, considering cognitive development, is recommended for age-appropriate HIV information delivery.

Area of Science:

  • Pediatric Infectious Diseases
  • Child Psychology
  • Public Health

Background:

  • Antiretroviral therapy (ART) availability increases lifespan for children with HIV/AIDS.
  • Disclosure of HIV status to infected children is a growing concern.
  • Cognitive development theories inform disclosure strategies.

Purpose of the Study:

  • To review literature on HIV disclosure to children.
  • To advocate for a process-oriented disclosure approach.
  • To address challenges faced by healthcare workers and caregivers.

Main Methods:

  • Literature review on HIV disclosure in pediatric populations.
  • Analysis of disclosure challenges through the lens of cognitive development.
  • Examination of healthcare provider and caregiver perspectives.

Main Results:

  • Healthcare workers generally support disclosure, while caregivers are often more reluctant.
  • Disclosure involves complex information control and best interest considerations.
  • Contradictory views on disclosure exist between healthcare providers and caregivers.

Conclusions:

  • A process-oriented approach is needed for discussing HIV with children.
  • Practical interventions are necessary to support age-appropriate pediatric HIV disclosure.
  • Effective disclosure requires tailored information delivery based on cognitive development.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Psychosexual Theory of Development01:14

Psychosexual Theory of Development

Sigmund Freud's psychosexual theory of development suggests that early childhood experiences significantly shape personality and behavior. Freud proposed that development is discontinuous, occurring in five distinct stages, each defined by a focus on different erogenous zones. He believed that failure to resolve the conflicts specific to each stage successfully could result in fixation, potentially influencing behavior as adults.
The Five Stages of Psychosexual Development
Freud's psychosexual...